Introduction: This service evaluation explored and reported findings from a new
| INTRODUCTION
Persistent shoulder pain accounts for 15% of all musculoskeletal conditions and is associated with high patient burden and healthcare costs (Borstand & Woeste, 2015; Meislin, Sperling, & Stitik, 2005) . Among patients seeking treatment for their shoulder pain, approximately half have ongoing symptoms 12 months from first consulting a health professional (Chester et al., 2013; Laslett, Steele, & Hing, 2015; van der Windt et al., 1996) . When persistent, shoulder pain is often thought to be multifactorial, involving pathology affecting more than one anatomical structure in the shoulder, potentially requiring more complex management (Meislin et al., 2005) . It is therefore important to identify effective clinical interventions that can address multiple factors simultaneously for patients with persistent musculoskeletal shoulder pain.
There is a moderate level of evidence from two systematic reviews to support the short-term effectiveness (for 12 weeks or less) of suprascapular nerve block (SSNB) injections for persistent shoulder (PT)-led exercise (Chang et al., 2016) . The usefulness of PT-led exercise in a chronically sensitized pain state requires careful consideration.
Peripheral input to the central nervous system resulting from stretching or strengthening exercises, while useful in the long-term management, can stimulate peripheral nociceptors and further aggravate the nociceptive barrage and potentially worsen pain (Borstad & Woeste, 2015) . Using SSNBs prior to providing a course of exercise could temporally break the afferent nociceptive input (Vadhanan, Tripaty, & Adinarayanan, 2015) and create an opportunity to proceed with more effective exercise rehabilitation in the short, medium and long term (Bialosky, Bishop, Price, Robinson, & George, 2009 ). There is limited evidence to date that supports the addition of exercise after SSNB (Di Lorenzo et al., 2006; Klç, Filiz, Çakr, & Toraman, 2015) .
SSNBs can be delivered using ultrasound, fluoroscopy and palpation-guided delivery techniques. It has been suggested that ultrasound and fluoroscopy techniques are less likely to result in serious complications such as pneumothorax and inadvertent neurovascular injury (Gorthi, Moon, & Kang, 2010; Vorster et al., 2008) . However, evidence exists to support the landmark-guided palpation method as a safe method of delivering SSNBs (Shanahan et al., 2003 (Shanahan et al., , 2004 ).
| Service model
At one National Health Service (NHS) hospital Trust in the West Midlands in England, patients with persistent shoulder pain had historically been referred to an anaesthetist for a therapeutic SSNB performed under ultrasound guidance. Waiting times for the procedure usually exceeded 1 month, having a negative impact on the national 18-week referral-to-treatment target. This target was set by the NHS Constitution to ensure that patients (with non-urgent problems) should wait no longer than 18 weeks from general practitioner referral to treatment in secondary care (NHS England, 2013) . Patients receiving SSNBs did not receive a physiotherapy referral following their nerve block but would be followed up in a clinic by an orthopaedic surgeon to evaluate short-term outcomes and decide on further onward management, if necessary (e.g. referral to a pain clinic).
It was decided to re-develop the service to explore alternative ways to deliver SSNBs to improve access to SSNB procedures for patients with persistent shoulder pain and improve follow-up care.
Advanced practitioner PTs based in secondary care, who had a specialist interest in shoulder pain management, were trained to perform palpation-guided SSNBs. All PTs had already been trained and were competent in injection therapy for the shoulder. Additional training in SSNBs was provided on a one-to-one basis in terms of a theoretical component on dose and risks, as well as an observational component on technique by either a consultant anaesthetist or consultant physiotherapist. A variable amount of observational training was required, depending on the individual physiotherapist, and ranged between one and five observed SSNBs. In addition to receiving an SSNB, patients were also prescribed home exercises from a PT. Patients received a 6-week follow-up appointment with a specialist PT, rather than the orthopaedic consultant. In addition, patients received a 6-month telephone follow-up by a physiotherapy assistant to establish medium-term clinical outcomes. This exploratory service evaluation collected patient-reported outcome data from patients who received PT-led SSNBs in combination with exercise, and provided an initial comparison with outcomes from patients who had received their SSNBs using ultrasound guidance from a medical doctor (in this case, an anaesthetist) in combination with exercise for patients with persistent shoulder pain.
| METHODS
This prospective service evaluation was conducted in the physiotherapy department of an NHS hospital Trust in the West Midlands, England. The aim was to recruit up to 50 patients within 1 year as this has been the recommended number of patients to be involved in a service evaluation of this kind (Clinical Audit Criteria and Guidance Working Group, 2008) . It was anticipated that some of the patients would receive an SSNB using an ultrasound-guided technique from an anaesthetist to enable an exploration of the outcomes achieved for each of the two approaches. Outcome measures were collected at baseline (prior to receiving an SSNB), at 6 weeks (short-term outcomes) and at 6 months (medium-term outcome) following the SSNB.
Patients provided written consent to be contacted by telephone review at 6 months as this was an additional requirement to their usual care. The service evaluation was approved and registered by the clini- 
| Participant population and data collection process
Patients were referred to physiotherapy from orthopaedic consultants, general practitioners or PTs working in a primary care setting. All patients were aged 18 years and over, and presented with persistent musculoskeletal shoulder pain, defined as pain lasting longer than 3 months and having failed to respond to previous interventions.
Patients were assessed by an advanced practitioner PT to determine suitability, prior to being offered an SSNB, which was provided 1 week later (as per standard practice).
Baseline data were collected in the physiotherapy clinic by the PTs immediately prior to the patient receiving the SSNB, regardless of whether the SSNB was provided by the anaesthetist or the PT. Baseline data included demographic data (age, gender and occupation), clinical characteristics (clinical diagnosis, previous treatment and pain duration, dominant arm and shoulder involved) and patient-reported outcome measures: pain measured using the numerical rating scale (NRS) (Hawker, 2011) ; function measured using the patient-specific functional score (PSFS) (Hefford, 
| SSNB delivery
Participants received a single SSNB either from a PT using a palpationguided technique (Meier technique, as described by Fernandes, Barbosa, Sousa, & Ramos, 2012a) (see Figure 1) or from a consultant anaesthetist using an ultrasound-guided technique. At the time of making the appointment for the SSNB, it was not known whether the patients would receive SSNBs from the anaesthetist or a PT. The decision on who would provide the SSNB was based on clinician availability on the day. During the course of the service evaluation, a number of clinics had been arranged for the anaesthetist to be involved in providing ultrasound-guided SSNBs. Due to unforeseen personal and work commitments, the anaesthetist was only available to attend few of the planned sessions, leading to a disproportionate number of patients being seen by the advanced practitioner PTs. Within the injectate, all patients received a corticosteroid (40 mg [1 mL] methylprednisolone acetate) and an anaesthetic (either 100 mg [10 mL) lidocaine hydrochloride or 50 mg (10 mL) levobupivacaine). An anaesthetic volume of 10 mL has been advocated for use in SSNBs (Fernandes, Barbosa, Sousa, & Ramos, 2012b) . Variability in anaesthetic medications meant that patients who had contraindications for one medication were able to receive an SSNB using the alternative medication.
All SSNBs (including those delivered by the anaesthetist) were delivered in the physiotherapy department. All patients (including those who had received their SSNBs from the anaesthetist) were advised to take relative rest for a period of 2 days following the procedure and were provided with prescribed, individualized home exercises by a PT. The provision of home exercises was not standardized. If any of the patients struggled to understand the exercises prior to the SSNB, a further physiotherapy appointment was arranged for after the SSNB. Additional physiotherapy appointments were not necessarily with advanced practitioners but were provided by one of the other PTs working in the shoulder pain service at the time.
| Outcome measures 2.3.1 | Pain intensity (NRS)
Patients were asked to mark the "worst" shoulder pain they had experienced in the preceding week on an NRS (0-10, where 0 represented "no pain at all" and 10 represented "worse pain imaginable"). The 0-10 NRS for pain is a validated and frequently used measure to assess changes in shoulder pain in response to interventions (Hawker, 2011) . A change of two points on a 0-10-point scale has been identified to represent a clinically meaningful change in shoulder pain (Michener, Snyder, & Leggin, 2011) . 
| Function (PSFS)
The PSFS is an outcome used to identify changes in physical function (Hefford et al., 2012; Koehorst et al., 2014) (Hefford et al., 2012) , and 1.3 points for shoulder pain specifically (Koehorst et al., 2014) . In the present service evaluation, a change of −1.3 points or more on the scale represented a meaningful improvement.
| Health-related quality of life (EQ5D-5 L)
The EQ5D-5 L (EuroQol Group, 2009 ) is a generic outcome measure, validated to identify changes in health-related quality of life (König et al., 2009) . It has been reported to have a good correlation with shoulder-specific questionnaires (Paul et al., 2004) . The scale asks five questions relating to physical and psychological domains, as well as asking the patient to score their health on a 0-100 health state thermometer. An online electronic formula calculates scores (available at http://www.euroqol.org/about-eq-5d/valuationof-eq-5d/eq-5d-5l-value-sets.html). These range from −0.11 (poor health) to 1 (full health) (Kind, Dolan, Gudex, & Williams, 1998; Revicki et al., 2009) . A clinically meaningful change in EQ5D-5 L score has been identified as 0.10 for patients with chronic musculoskeletal pain conditions (Yoshizawa et al., 2016) . Baseline results ( Table 1 ).indicated that both groups had similar characteristics for most variables. Patients in both groups generally had high pain scores (mean NRS = 7.8) and low functional scores (mean PSFS = 3.4) at baseline. All had received previous interventions, the majority of which were conservative treatments in the form of different treatment modalities used in physiotherapy and previous injections around the shoulder (intra-articular and/or soft-tissue). No patients had previously received SSNBs. The majority of patients in both groups were assessed clinically and diagnosed with multiple components contributing to their shoulder pain -for example, rotator cuff disorder with acromioclavicular joint osteoarthritis. Follow-up rates at 6 weeks were good, with data available for 45 patients (93%) for pain intensity (NRS), 42 (88%) for function (PSFS) and 43 (90%) for quality of life (EQ5D-5 L). Follow-up rates remained good at 6 months, with pain intensity data available for 42 patients (88%). There were no reports of harm associated with the procedure, and none of the patients required anything other than standard aftercare (30-min rest in the department following the SSNB). One patient (in the PT-led SSNB group) reported to have felt lightheaded following the procedure; this resolved a few hours following the SSNB. Table 2 presents the results at baseline, and the 6-week and 6-month (for pain [NRS] measures) follow-up, for both patient groups.
| Outcomes

| Pain intensity (NRS)
Mean pain intensity decreased from 7.7 at baseline to 5.5 at the 6-week follow-up and 5.7 at the 6-month follow-up in the PT group. The mean improvement from baseline was clinically meaningful and statistically significant at 6 weeks (mean change 2.2; 95% confidence interval [CI] 1.3 to 3.0), and at 6 months (mean change 2.0; 95% CI 0.99 to 2.95). In the anaesthetist group, mean pain intensity decreased from 7.8 to 6.5 at 6 weeks and 5.3 at 6 months follow-up. Mean improvements in the anaesthetist group were not statistically significant at either time point but did reach the predefined threshold for a clinically meaningful improvement at 6 months (see Figure 2 ; Table 2 ).
| Function (PSFS)
Mean function increased from 3.6 at baseline to 4.9 at the 6-week follow-up in the PT group. Mean improvement was clinically meaningful and statistically significant at 6 weeks (mean change −1.3; 95% CI -1.9 to −0.4). In the anaesthetist group, mean function increased from 2.9 at baseline to 4.6 at 6 weeks. These changes were also clinically meaningful, but not statistically significant, at 6 weeks (−1.41; 95% CI -3.18 to 0.35).
| Health-related quality of life (EQ5D-5 L)
At the 6-week follow-up, health-related quality of life increased from 0.46 at baseline to 0.50 in the PT group, and from 0.38 to 0.46 in the anaesthetist group. The changes from baseline in neither group met the cut-off point for a meaningful change or were statistically significant (p > 0.05).
| DISCUSSION
Patients with persistent shoulder pain receiving SSNBs delivered by advanced practitioner PTs using a palpation-guided technique with accompanying prescribed exercise reported clinically meaningful reductions in pain and function in the short term. Improvements in pain were maintained in the medium term. The improvements observed were similar to those achieved by ultrasound-guided SSNBs given by an anaesthetist. Findings from the present service evaluation have resulted in a change to service delivery at the NHS hospital Trust in which the service evaluation was conducted. All patients attending the orthopaedic services who require a therapeutic SSNB are now referred to a PT rather than to an anaesthetist.
The mean change in pain at 6 weeks after the SSNB for the PTled group was 2.2. which represented a clinically meaningful difference. Studies evaluating landmark-guided SSNBs on mixed pathology chronic shoulder patients have reported mean reductions in pain of less than this: 1.2 at 4-week follow-up (Shanahan et al., 2004) , 0.6 at 1-month follow-up (Taskaynatan, Yilmaz, Ozgul, Yazicioglu, & Kalyon, 2005) , and 1.3 and 0.5 at 12-week follow-up (Shanahan et al., 2003 (Shanahan et al., , 2004 . Unlike those previous studies, in the present service evaluation, SSNBs were provided by PTs in conjunction with prescribed, individualized exercise.
Previous studies have evaluated the benefit of SSNBs with PT-led exercises but it is not clear whether PTs also provided the SSNBs (Dahan et al., 2000; Di Lorenzo et al., 2006; Klç et al., 2015) . To the authors' knowledge, the present study was the first formal evaluation of the outcomes of shoulder pain patients following provision of SSNBs with exercise by a PT.
With respect to the injection technique, the findings from the present service evaluation are consistent with other reports that palpation-guided SSNBs are as safe as ultrasound-guided procedures EQ5D-5 L = EuroQol, five dimensions questionnaire; n = number of participants; NRS, numerical rating scale; PSFS, patient-specific functional score; SD, standard deviation; SSNB, suprascapular nerve block.
FIGURE 2 Mean point scores with 95% confidence interval (CI) for pain (numerical rating scale [NRS]) at baseline, and the 6-week and 6-month follow-up (Di Lorenzo et al., 2006; Jones & Chattopadhyay, 1999; Nam et al., 2011; Shanahan et al., 2003; Taskaynatan et al., 2005) . This has implications for overall cost, in terms of the ultrasound equipment, The evaluation also had some strengths: it was the first to provide an exploratory evaluation of SSNBs delivered by PTs, and presented outcomes up to 6 months after the intervention. No published research studies evaluating SSNBs to date have followed up participants after SSNB beyond 12 weeks. In addition, it provided some early suggestion that SSNBs delivered by PTs might be as effective as those provided by medical doctors. A recent study comparing the efficacy of PTs providing steroid injections (in this case, to the subacromial region of the shoulder) with that of medical doctors reported equivocal outcomes (Marks et al., 2016) . Research that tests the effectiveness of adding SSNBs to PT-led exercise for persistent shoulder pain is needed.
| Implications
The present service evaluation provides exploratory evidence that 
